{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T12:35:59Z","timestamp":1778070959389,"version":"3.51.4"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T00:00:00Z","timestamp":1735776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T00:00:00Z","timestamp":1735776000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004622","name":"KWF Kankerbestrijding","doi-asserted-by":"publisher","award":["11289"],"award-info":[{"award-number":["11289"]}],"id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017636","name":"Cancer Center Amsterdam","doi-asserted-by":"crossref","award":["2021-2-29"],"award-info":[{"award-number":["2021-2-29"]}],"id":[{"id":"10.13039\/501100017636","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100011475","name":"Cholangiocarcinoma Foundation","doi-asserted-by":"publisher","award":["Cholangiocarcinoma Foundation"],"award-info":[{"award-number":["Cholangiocarcinoma Foundation"]}],"id":[{"id":"10.13039\/100011475","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1007\/s00259-024-07037-6","type":"journal-article","created":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T02:13:27Z","timestamp":1735784007000},"page":"1472-1480","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Assessment of fully quantitative and simplified methods for analysis of [68Ga]Ga-FAPI-46 uptake in patients with pancreatobiliary cancer using LAFOV PET\/CT"],"prefix":"10.1007","volume":"52","author":[{"given":"Xavier","family":"Palard-Novello","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rutger B.","family":"Henrar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela E.","family":"Oprea-Lager","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthijs C. F.","family":"Cysouw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Schober","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lioe-Fee","family":"de Geus-Oei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander L.","family":"Vahrmeijer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harry","family":"Hendrikse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geert","family":"Kazemier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marijke","family":"den Hollander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert C.","family":"Schuit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert D.","family":"Windhorst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald","family":"Boellaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rutger-Jan","family":"Swijnenburg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maqsood","family":"Yaqub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,2]]},"reference":[{"issue":"6","key":"7037_CR1","doi-asserted-by":"publisher","first-page":"801","DOI":"10.2967\/jnumed.119.227967","volume":"60","author":"C Kratochwil","year":"2019","unstructured":"Kratochwil C, Flechsig P, Lindner T, et al. 68Ga-FAPI PET\/CT: Tracer Uptake in 28 Different Kinds of Cancer. J Nucl Med. 2019;60(6):801\u20135. https:\/\/doi.org\/10.2967\/jnumed.119.227967.","journal-title":"J Nucl Med"},{"issue":"5","key":"7037_CR2","doi-asserted-by":"publisher","first-page":"711","DOI":"10.2967\/jnumed.122.264689","volume":"64","author":"N Hirmas","year":"2023","unstructured":"Hirmas N, Hamacher R, Sraieb M, et al. Fibroblast-Activation Protein PET and Histopathology in a Single-Center Database of 324 Patients and 21 Tumor Entities. J Nucl Med. 2023;64(5):711\u20136. https:\/\/doi.org\/10.2967\/jnumed.122.264689.","journal-title":"J Nucl Med"},{"issue":"2","key":"7037_CR3","doi-asserted-by":"publisher","first-page":"266","DOI":"10.2967\/jnumed.120.244723","volume":"62","author":"Y Luo","year":"2021","unstructured":"Luo Y, Pan Q, Yang H, Peng L, Zhang W, Li F. Fibroblast Activation Protein-Targeted PET\/CT with 68Ga-FAPI for Imaging IgG4-Related Disease: Comparison to 18F-FDG PET\/CT. J Nucl Med. 2021;62(2):266\u201371. https:\/\/doi.org\/10.2967\/jnumed.120.244723.","journal-title":"J Nucl Med"},{"issue":"2","key":"7037_CR4","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s00259-021-05472-3","volume":"49","author":"C Qin","year":"2022","unstructured":"Qin C, Song Y, Liu X, et al. Increased uptake of 68Ga-DOTA-FAPI-04 in bones and joints: metastases and beyond. Eur J Nucl Med Mol Imaging. 2022;49(2):709\u201320. https:\/\/doi.org\/10.1007\/s00259-021-05472-3.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"12","key":"7037_CR5","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.2967\/jnumed.122.264205","volume":"63","author":"C Schmidkonz","year":"2022","unstructured":"Schmidkonz C, Kuwert T, Atzinger A, et al. Fibroblast Activation Protein Inhibitor Imaging in Nonmalignant Diseases: A New Perspective for Molecular Imaging. J Nucl Med. 2022;63(12):1786\u201392. https:\/\/doi.org\/10.2967\/jnumed.122.264205.","journal-title":"J Nucl Med"},{"issue":"11","key":"7037_CR6","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.2967\/jnumed.123.266182","volume":"64","author":"C Schmidkonz","year":"2023","unstructured":"Schmidkonz C, Atzinger A, Ramming A, Kuwert T. FAPI PET\/CT Immune-Fibrosis Imaging for New Insights into Rheumatologic Disorders. J Nucl Med. 2023;64(11):1674\u20135. https:\/\/doi.org\/10.2967\/jnumed.123.266182.","journal-title":"J Nucl Med"},{"issue":"9","key":"7037_CR7","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.2967\/jnumed.118.210435","volume":"59","author":"A Loktev","year":"2018","unstructured":"Loktev A, Lindner T, Mier W, et al. A Tumor-Imaging Method Targeting Cancer-Associated Fibroblasts. J Nucl Med. 2018;59(9):1423\u20139. https:\/\/doi.org\/10.2967\/jnumed.118.210435.","journal-title":"J Nucl Med"},{"issue":"2","key":"7037_CR8","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1038\/s41379-020-00656-y","volume":"34","author":"N Guedj","year":"2021","unstructured":"Guedj N, Blaise L, Cauchy F, Albuquerque M, Soubrane O, Paradis V. Prognostic value of desmoplastic stroma in intrahepatic cholangiocarcinoma. Mod Pathol. 2021;34(2):408\u201316. https:\/\/doi.org\/10.1038\/s41379-020-00656-y.","journal-title":"Mod Pathol"},{"key":"7037_CR9","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s13045-017-0448-5","volume":"10","author":"D von Ahrens","year":"2017","unstructured":"von Ahrens D, Bhagat TD, Nagrath D, Maitra A, Verma A. The role of stromal cancer-associated fibroblasts in pancreatic cancer. J Hematol Oncol. 2017;10:76. https:\/\/doi.org\/10.1186\/s13045-017-0448-5.","journal-title":"J Hematol Oncol"},{"issue":"10","key":"7037_CR10","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.2967\/jnumed.118.224469","volume":"60","author":"A Loktev","year":"2019","unstructured":"Loktev A, Lindner T, Burger EM, et al. Development of Fibroblast Activation Protein\u2013Targeted Radiotracers with Improved Tumor Retention. J Nucl Med. 2019;60(10):1421\u20139. https:\/\/doi.org\/10.2967\/jnumed.118.224469.","journal-title":"J Nucl Med"},{"key":"7037_CR11","doi-asserted-by":"publisher","unstructured":"Glatting FM, Hoppner J, Liew DP, et al. Repetitive early FAPI-PET acquisition comparing FAPI-02, FAPI-46 and FAPI-74: methodological and diagnostic implications for malignant, inflammatory and degenerative lesions. J Nuclear Med Published online May. 2022;1. https:\/\/doi.org\/10.2967\/jnumed.122.264069.","DOI":"10.2967\/jnumed.122.264069"},{"issue":"12","key":"7037_CR12","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.2967\/jnumed.122.264827","volume":"64","author":"L Kessler","year":"2023","unstructured":"Kessler L, Hirmas N, Pabst KM, et al. 68Ga-Labeled Fibroblast Activation Protein Inhibitor (68Ga-FAPI) PET for Pancreatic Adenocarcinoma: Data from the 68Ga-FAPI PET Observational Trial. J Nucl Med. 2023;64(12):1910\u20137. https:\/\/doi.org\/10.2967\/jnumed.122.264827.","journal-title":"J Nucl Med"},{"issue":"7","key":"7037_CR13","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.2967\/jnumed.122.265215","volume":"64","author":"KM Pabst","year":"2023","unstructured":"Pabst KM, Trajkovic-Arsic M, Cheung PFY, et al. Superior Tumor Detection for 68Ga-FAPI-46 Versus 18F-FDG PET\/CT and Conventional CT in Patients with Cholangiocarcinoma. J Nucl Med. 2023;64(7):1049\u201355. https:\/\/doi.org\/10.2967\/jnumed.122.265215.","journal-title":"J Nucl Med"},{"issue":"10242","key":"7037_CR14","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1016\/S0140-6736(20)30974-0","volume":"395","author":"JD Mizrahi","year":"2020","unstructured":"Mizrahi JD, Surana R, Valle JW, Shroff RT. Pancreatic cancer. Lancet. 2020;395(10242):2008\u201320. https:\/\/doi.org\/10.1016\/S0140-6736(20)30974-0.","journal-title":"Lancet"},{"issue":"9","key":"7037_CR15","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1158\/2159-8290.CD-17-0245","volume":"7","author":"JW Valle","year":"2017","unstructured":"Valle JW, Lamarca A, Goyal L, Barriuso J, Zhu AX. New Horizons for Precision Medicine in Biliary Tract Cancers. Cancer Discov. 2017;7(9):943\u201362. https:\/\/doi.org\/10.1158\/2159-8290.CD-17-0245.","journal-title":"Cancer Discov"},{"issue":"3","key":"7037_CR16","doi-asserted-by":"publisher","first-page":"200825","DOI":"10.1016\/j.omton.2024.200825","volume":"32","author":"N Amhis","year":"2024","unstructured":"Amhis N, Carignan J, Tai LH. Transforming pancreaticobiliary cancer treatment: Exploring the frontiers of adoptive cell therapy and cancer vaccines. Mol Ther Oncol. 2024;32(3):200825. https:\/\/doi.org\/10.1016\/j.omton.2024.200825.","journal-title":"Mol Ther Oncol"},{"issue":"3","key":"7037_CR17","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1109\/trpms.2020.2985403","volume":"4","author":"S Surti","year":"2020","unstructured":"Surti S, Pantel AR, Karp JS, Total Body PET. Why, How, What for? IEEE Trans Radiat Plasma Med Sci. 2020;4(3):283\u201392. https:\/\/doi.org\/10.1109\/trpms.2020.2985403.","journal-title":"IEEE Trans Radiat Plasma Med Sci"},{"key":"7037_CR18","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.nucmedbio.2022.04.010","volume":"110\u2013111","author":"M Nader","year":"2022","unstructured":"Nader M, Valla DF, Vriamont C, et al. [68Ga]\/[90Y]FAPI-46: Automated production and analytical validation of a theranostic pair. Nucl Med Biol. 2022;110\u2013111:37\u201344. https:\/\/doi.org\/10.1016\/j.nucmedbio.2022.04.010.","journal-title":"Nucl Med Biol"},{"issue":"supplement 1","key":"7037_CR19","first-page":"1753","volume":"59","author":"Ronald Boellaard","year":"2018","unstructured":"Ronald Boellaard. Quantitative oncology molecular analysis suite: ACCURATE. J Nucl Med. 2018;59(supplement 1):1753.","journal-title":"J Nucl Med"},{"issue":"1","key":"7037_CR20","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s40658-024-00628-0","volume":"11","author":"X Palard-Novello","year":"2024","unstructured":"Palard-Novello X, Visser D, Tolboom N, et al. Validation of image-derived input function using a long axial field of view PET\/CT scanner for two different tracers. EJNMMI Phys. 2024;11(1):25. https:\/\/doi.org\/10.1186\/s40658-024-00628-0.","journal-title":"EJNMMI Phys"},{"issue":"6","key":"7037_CR21","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1097\/00004647-200106000-00002","volume":"21","author":"RN Gunn","year":"2001","unstructured":"Gunn RN, Gunn SR, Cunningham VJ. Positron emission tomography compartmental models. J Cereb Blood Flow Metab. 2001;21(6):635\u201352. https:\/\/doi.org\/10.1097\/00004647-200106000-00002.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"7","key":"7037_CR22","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/s0969-8051(00)00137-2","volume":"27","author":"J Logan","year":"2000","unstructured":"Logan J. Graphical analysis of PET data applied to reversible and irreversible tracers. Nucl Med Biol. 2000;27(7):661\u201370. https:\/\/doi.org\/10.1016\/s0969-8051(00)00137-2.","journal-title":"Nucl Med Biol"},{"issue":"2","key":"7037_CR23","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1007\/s00259-014-2961-x","volume":"42","author":"R Boellaard","year":"2015","unstructured":"Boellaard R, Delgado-Bolton R, Oyen WJG, et al. FDG PET\/CT: EANM procedure guidelines for tumour imaging: version 2.0. Eur J Nucl Med Mol Imaging. 2015;42(2):328\u201354. https:\/\/doi.org\/10.1007\/s00259-014-2961-x.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"6","key":"7037_CR24","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1109\/TAC.1974.1100705","volume":"19","author":"H Akaike","year":"1974","unstructured":"Akaike H. A new look at the statistical model identification. IEEE Trans Autom Control. 1974;19(6):716\u201323. https:\/\/doi.org\/10.1109\/TAC.1974.1100705.","journal-title":"IEEE Trans Autom Control"},{"issue":"6","key":"7037_CR25","doi-asserted-by":"publisher","first-page":"960","DOI":"10.2967\/jnumed.122.264988","volume":"64","author":"R Chen","year":"2023","unstructured":"Chen R, Yang X, Ng YL, et al. First Total-Body Kinetic Modeling and Parametric Imaging of Dynamic 68Ga-FAPI-04 PET in Pancreatic and Gastric Cancer. J Nucl Med. 2023;64(6):960\u20137. https:\/\/doi.org\/10.2967\/jnumed.122.264988.","journal-title":"J Nucl Med"},{"issue":"3","key":"7037_CR26","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1007\/s00259-022-06010-5","volume":"50","author":"R Chen","year":"2023","unstructured":"Chen R, Yang X, Yu X, et al. Tumor-to-blood ratio for assessment of fibroblast activation protein receptor density in pancreatic cancer using [68Ga]Ga-FAPI-04. Eur J Nucl Med Mol Imaging. 2023;50(3):929\u201336. https:\/\/doi.org\/10.1007\/s00259-022-06010-5.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"9","key":"7037_CR27","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.2967\/jnumed.118.210443","volume":"59","author":"T Lindner","year":"2018","unstructured":"Lindner T, Loktev A, Altmann A, et al. Development of Quinoline-Based Theranostic Ligands for the Targeting of Fibroblast Activation Protein. J Nucl Med. 2018;59(9):1415\u201322. https:\/\/doi.org\/10.2967\/jnumed.118.210443.","journal-title":"J Nucl Med"},{"issue":"6","key":"7037_CR28","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1007\/s00259-021-05653-0","volume":"49","author":"P Backhaus","year":"2022","unstructured":"Backhaus P, Gierse F, Burg MC, et al. Translational imaging of the fibroblast activation protein (FAP) using the new ligand [68Ga]Ga-OncoFAP-DOTAGA. Eur J Nucl Med Mol Imaging. 2022;49(6):1822\u201332. https:\/\/doi.org\/10.1007\/s00259-021-05653-0.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"8","key":"7037_CR29","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.2967\/jnumed.119.236786","volume":"61","author":"C Meyer","year":"2020","unstructured":"Meyer C, Dahlbom M, Lindner T, et al. Radiation Dosimetry and Biodistribution of 68Ga-FAPI-46 PET Imaging in Cancer Patients. J Nucl Med. 2020;61(8):1171\u20137. https:\/\/doi.org\/10.2967\/jnumed.119.236786.","journal-title":"J Nucl Med"},{"issue":"6","key":"7037_CR30","doi-asserted-by":"publisher","first-page":"872","DOI":"10.2967\/jnumed.123.267103","volume":"65","author":"M R\u00f6hrich","year":"2024","unstructured":"R\u00f6hrich M, Daum J, Gutjahr E, et al. Diagnostic Potential of Supplemental Static and Dynamic 68Ga-FAPI-46 PET for Primary 18F-FDG-Negative Pulmonary Lesions. J Nucl Med. 2024;65(6):872\u20139. https:\/\/doi.org\/10.2967\/jnumed.123.267103.","journal-title":"J Nucl Med"},{"issue":"1","key":"7037_CR31","doi-asserted-by":"publisher","first-page":"17848","DOI":"10.1038\/s41598-023-43049-2","volume":"13","author":"J Hoppner","year":"2023","unstructured":"Hoppner J, van Genabith L, Hielscher T, et al. Comparison of early and late 68Ga-FAPI-46-PET in 33 patients with possible recurrence of pancreatic ductal adenocarcinomas. Sci Rep. 2023;13(1):17848. https:\/\/doi.org\/10.1038\/s41598-023-43049-2.","journal-title":"Sci Rep"},{"issue":"6","key":"7037_CR32","doi-asserted-by":"publisher","first-page":"779","DOI":"10.2967\/jnumed.120.253062","volume":"62","author":"M R\u00f6hrich","year":"2021","unstructured":"R\u00f6hrich M, Naumann P, Giesel FL, et al. Impact of 68Ga-FAPI PET\/CT Imaging on the Therapeutic Management of Primary and Recurrent Pancreatic Ductal Adenocarcinomas. J Nucl Med. 2021;62(6):779\u201386. https:\/\/doi.org\/10.2967\/jnumed.120.253062.","journal-title":"J Nucl Med"},{"issue":"4","key":"7037_CR33","doi-asserted-by":"publisher","first-page":"618","DOI":"10.2967\/jnumed.122.264941","volume":"64","author":"M Naeimi","year":"2023","unstructured":"Naeimi M, Choyke PL, Dendl K, et al. Three-Time-Point PET Analysis of 68Ga-FAPI-46 in a Variety of Cancers. J Nucl Med. 2023;64(4):618\u201322. https:\/\/doi.org\/10.2967\/jnumed.122.264941.","journal-title":"J Nucl Med"},{"issue":"21","key":"7037_CR34","doi-asserted-by":"publisher","first-page":"5301","DOI":"10.3390\/cancers14215301","volume":"14","author":"FM Glatting","year":"2022","unstructured":"Glatting FM, Hoppner J, Kauczor HU, et al. Subclass Analysis of Malignant, Inflammatory and Degenerative Pathologies Based on Multiple Timepoint FAPI-PET Acquisitions Using FAPI-02, FAPI-46 and FAPI-74. Cancers (Basel). 2022;14(21):5301. https:\/\/doi.org\/10.3390\/cancers14215301.","journal-title":"Cancers (Basel)"},{"issue":"5","key":"7037_CR35","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1053\/j.semnuclmed.2023.02.001","volume":"53","author":"M Bentestuen","year":"2023","unstructured":"Bentestuen M, Al-Obaydi N, Zacho HD. FAPI-avid nonmalignant PET\/CT findings: An expedited systematic review. Semin Nucl Med. 2023;53(5):694\u2013705. https:\/\/doi.org\/10.1053\/j.semnuclmed.2023.02.001.","journal-title":"Semin Nucl Med"},{"issue":"10","key":"7037_CR36","doi-asserted-by":"publisher","first-page":"3221","DOI":"10.1007\/s00259-021-05266-7","volume":"48","author":"J Ferdinandus","year":"2021","unstructured":"Ferdinandus J, Kessler L, Hirmas N, et al. Equivalent tumor detection for early and late FAPI-46 PET acquisition. Eur J Nucl Med Mol Imaging. 2021;48(10):3221\u20137. https:\/\/doi.org\/10.1007\/s00259-021-05266-7.","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-024-07037-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-024-07037-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-024-07037-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T10:54:56Z","timestamp":1739962496000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-024-07037-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,2]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["7037"],"URL":"https:\/\/doi.org\/10.1007\/s00259-024-07037-6","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,2]]},"assertion":[{"value":"10 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Patients were included in studies approved by the Medical Ethics Review Committee of the Amsterdam UMC (Institutional review board number 2022.0640) and performed in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"No potential conflict of interest relevant to this article was reported.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}